KLHL21通过维持胃稳态中STAT3信号平衡抑制胃肿瘤发生
本研究整合分析化生与异型增生相关基因,经单细胞RNA测序和免疫染色在患者胃组织验证,并用条件敲除Klhl21小鼠模型探究其在干细胞性、DNA损伤和肿瘤形成中的作用。结果显示KLHL21在化生、异型增生和癌中表达逐渐降低,其缺失通过稳定PABPC1-eIF4G复合物促进PIK3CB mRNA翻译而激活STAT3,TTI-101抑制STAT3可阻碍化生向异型增生转变。
要点
- KLHL21在胃黏膜化生、异型增生和癌中表达逐渐降低。
- Klhl21缺失经PABPC1-PIK3CB轴激活STAT3,增强自我更新和致瘤性。
- TTI-101药理抑制STAT3可阻碍化生向异型增生转变。
核心结论
- KLHL21缺失通过PABPC1介导的PIK3CB翻译激活触发STAT3再激活,靶向STAT3可逆转KLHL21缺陷胃中的癌前化生。
研究设计与样本
- 对化生、异型增生相关基因进行整合分析,并在患者胃组织中用单细胞RNA测序和免疫染色验证和表征。
- 构建多个小鼠模型,包括Klhl21-floxed纯合条件敲除小鼠,以探究Klhl21缺失在干细胞性、DNA损伤和肿瘤形成中的作用。
- 采用基于质谱的蛋白质组学和核糖体测序阐明潜在分子机制。
主要发现
- Kelch样蛋白21(KLHL21)在化生、异型增生和癌中表达逐渐降低。
- Klhl21基因缺失增强Mist1+细胞及其子代细胞的快速增殖。
- 化生期间Klhl21缺失通过STAT3信号促进损伤细胞进入细胞周期。
- 缺乏KLHL21的癌细胞中STAT3活性增加,增强自我更新和致瘤性。
- KLHL21缺失通过稳定PABPC1-eIF4G复合物促进PIK3CB mRNA翻译,随后引起STAT3激活。
关键数值与推荐
- TTI-101药理抑制STAT3产生抗癌效应,有效阻碍化生向异型增生转变。
- 胃癌患者中KLHL21低水平者生存率更短且辅助化疗反应更差。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Precancerous metaplasia transition to dysplasia poses a risk for subsequent intestinal-type gastric adenocarcinoma. However, the molecular basis underlying the transformation from metaplastic to cancerous cells remains poorly understood. DESIGN: An integrated analysis of genes associated with metaplasia, dysplasia was conducted, verified and characterised in the gastric tissues of patients by single-cell RNA sequencing and immunostaining. Multiple mouse models, including homozygous conditional knockout Klhl21-floxed mice, were generated to investigate the role of Klhl21 deletion in stemness, DNA damage and tumour formation. Mass-spectrometry-based proteomics and ribosome sequencing were used to elucidate the underlying molecular mechanisms. RESULTS: Kelch-like protein 21 (KLHL21) expression progressively decreased in metaplasia, dysplasia and cancer. Genetic deletion of Klhl21 enhances the rapid proliferation of Mist1+ cells and their descendant cells. Klhl21 loss during metaplasia facilitates the recruitment of damaged cells into the cell cycle via STAT3 signalling. Increased STAT3 activity was confirmed in cancer cells lacking KLHL21, boosting self-renewal and tumourigenicity. Mechanistically, the loss of KLHL21 promotes PIK3CB mRNA translation by stabilising the PABPC1-eIF4G complex, subsequently causing STAT3 activation. Pharmacological STAT3 inhibition by TTI-101 elicited anticancer effects, effectively impeding the transition from metaplasia to dysplasia. In patients with gastric cancer, low levels of KLHL21 had a shorter survival rate and a worse response to adjuvant chemotherapy. CONCLUSIONS: Our findings highlighted that KLHL21 loss triggers STAT3 reactivation through PABPC1-mediated PIK3CB translational activation, and targeting STAT3 can reverse preneoplastic metaplasia in KLHL21-deficient stomachs.
引用
- Huang XB, Huang Q, Jiang MC, et al. KLHL21 suppresses gastric tumourigenesis via maintaining STAT3 signalling equilibrium in stomach homoeostasis. Gut. 2024. PMID: 38969490. doi:10.1136/gutjnl-2023-331111
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。